Literature DB >> 25131721

Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patients.

D Fuster1, A Sanvisens, F Bolao, I Serra, I Rivas, J Tor, R Muga.   

Abstract

Hepatitis C virus (HCV) infection is frequent among patients with alcohol use disorders. We aimed to analyse the impact of HCV infection on survival of patients seeking treatment for alcohol use. This was a longitudinal study in a cohort of patients who abused alcohol recruited in two detoxification units. Socio-demographic and alcohol use characteristics, liver function tests for the assessment of alcohol-related liver disease and HCV and HIV infection serologies were obtained at admission. Patients were followed until December 2008; causes of death were ascertained through clinical records and death registry. Cox models were used to analyse predictors of death. A total of 675 patients (79.7% men) were admitted; age at admission was 43.5 years (IQR: 37.9-50.2 years), duration of alcohol abuse was 18 years (IQR: 11-24 years), and median alcohol consumption was 200 g/day (IQR: 120-275 g/day). Distribution of patients according to viral infections was as follows: 75.7% without HCV or HIV infection, 14.7% HCV infection alone and 8.1% HCV/HIV coinfection. Median follow-up was 3.1 years (IQR: 1.5-5.1 years) accounting for 2,345 person-years. At the end of study, 78 patients (11.4%) had died. In the multivariate analysis, age at admission (HR = 1.71, 95%CI: 1.05-2.80), alcohol-related liver disease (HR = 3.55, 95%CI: 1.93-6.53) and HCV/HIV co-infection (HR = 3.86 95%CI: 2.10-7.11) were predictors of death. Younger patients (≤43 years) with HCV infection were more likely to die than those without viral infections (HR = 3.1, 95%CI: 1.3-7.3; P = 0.007). Among patients with alcohol-related liver disease, mortality rate was high, irrespective of viral infections. These data show that HCV infection confers a worse prognosis in patients with alcohol use disorders.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  HCV infection; alcohol dependence; liver-related mortality; survival

Mesh:

Year:  2014        PMID: 25131721     DOI: 10.1111/jvh.12290

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  6 in total

1.  Influence of comorbid drug use disorder on receipt of evidence-based treatment for alcohol use disorder among VA patients with alcohol use disorder and Hepatitis C and/or HIV.

Authors:  Madeline C Frost; Theresa E Matson; Judith I Tsui; Emily C Williams
Journal:  Drug Alcohol Depend       Date:  2018-10-30       Impact factor: 4.492

2.  The Role of Aging, Drug Dependence, and Hepatitis C Comorbidity in Alcoholism Cortical Compromise.

Authors:  Edith V Sullivan; Natalie M Zahr; Stephanie A Sassoon; Wesley K Thompson; Dongjin Kwon; Kilian M Pohl; Adolf Pfefferbaum
Journal:  JAMA Psychiatry       Date:  2018-05-01       Impact factor: 21.596

Review 3.  Update on Alcohol and Viral Hepatitis.

Authors:  Stefano Gitto; Giovanni Vitale; Erica Villa; Pietro Andreone
Journal:  J Clin Transl Hepatol       Date:  2014-12-15

Review 4.  Use of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary care.

Authors:  Jinhee Lee; Thomas F Kresina; Melinda Campopiano; Robert Lubran; H Westley Clark
Journal:  Biomed Res Int       Date:  2015-01-05       Impact factor: 3.411

Review 5.  Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections.

Authors:  Daniel Fuster; Arantza Sanvisens; Ferran Bolao; Inmaculada Rivas; Jordi Tor; Robert Muga
Journal:  World J Hepatol       Date:  2016-11-08

6.  Markers of inflammation and mortality in a cohort of patients with alcohol dependence.

Authors:  Daniel Fuster; Arantza Sanvisens; Ferran Bolao; Paola Zuluaga; Inmaculada Rivas; Jordi Tor; Robert Muga
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.